This content is machine translated Dupilumab EU approval for severe chronic rhinosinusitis with polyposis nasi The monoclonal antibody dupilumab, which has already been approved by the European Medicines Agency (EMA) for the treatment of atopic dermatitis and asthma, is now also available for patients with…
